Skip to main content
. 2014 Sep 21;20(35):12615–12620. doi: 10.3748/wjg.v20.i35.12615

Table 1.

Univariate analysis of risk factors for combined hepatocellular-cholangiocarcinoma n (%)

Risk factor Cases (n = 126) Controls (n = 504) OR (95%CI) P value
HBV < 0.001
HBsAg (-) 38 (30.2) 446 (88.5) 1 (Reference)
HBsAg (+) 88 (69.8) 58 (11.5) 17.808 (11.145-28.452)
HCV 0.563
HCV-Ab (-) 125 (99.2) 502 (99.6) 1 (Reference)
HCV-Ab (+) 1 (0.8) 2 (0.4) 2.008 (0.181-22.322)
Heavy smoking 0.395
No 88 (69.8) 371 (73.6) 1 (Reference)
Yes 38 (30.2) 133 (26.4) 1.205 (0.784-1.850)
Heavy alcohol consumption 0.018
No 105 (83.3) 457 (90.7) 1 (Reference)
Yes 21 (16.7) 47 (9.3) 1.945 (1.115-3.392)
Diabetes mellitus 0.024
No 113 (89.7) 479 (95.0) 1 (Reference)
Yes 13 (10.3) 25 (5.0) 2.204 (1.094-4.443)
Hypertension 0.855
No 110 (87.3) 443 (87.9) 1 (Reference)
Yes 16 (12.7) 61 (12.1) 1.056 (0.586-1.903)
Hepatolithiasis 0.262
No 124 (98.4) 501 (99.4) 1 (Reference)
Yes 2 (1.6) 3 (0.6) 2.694 (0.445-16.294)
Family history of liver cancer < 0.001
No 108 (85.7) 489 (97.0) 1 (Reference)
Yes 18 (14.3) 15 (3.0) 5.433 (2.655-11.120)
Family history of other malignancies 0.636
No 99 (78.6) 386 (76.6) 1 (Reference)
Yes 27 (21.4) 118 (23.4) 0.892 (0.556-1.431)

HBV: Hepatitis B virus; HCV: Hepatitis C virus; HbsAg: Hepatitis B surface antigen; HCV-Ab: Anti-HCV antibody.